Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-018061

Director sold 6,667 shares at $13.90 ($92,671)

  • Director acquired 6,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ABERCROMBIE GEORGE B · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-24 Exercise or conversion : show line 1 in the form +6,667 $2.63 $17,534 9,667 D
2021-05-24 Sale : show line 2 in the form −6,667 $13.90 $92,671 3,000 D
Open-market sales · 6,667 sh · avg $13.90 · $92,671

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-24 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option −6,667 10,000 D
Loading xslF345X03/form4.xml…